Dare Bioscience (DARE) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $1.8 million.
- Dare Bioscience's Accounts Payables rose 7592.25% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 7592.25%. This contributed to the annual value of $1.5 million for FY2024, which is 5699.87% down from last year.
- As of Q3 2025, Dare Bioscience's Accounts Payables stood at $1.8 million, which was up 7592.25% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Dare Bioscience's Accounts Payables registered a high of $6.5 million during Q2 2023, and its lowest value of $216043.0 during Q2 2021.
- In the last 5 years, Dare Bioscience's Accounts Payables had a median value of $1.9 million in 2024 and averaged $2.4 million.
- In the last 5 years, Dare Bioscience's Accounts Payables crashed by 8739.6% in 2021 and then soared by 48705.35% in 2023.
- Quarter analysis of 5 years shows Dare Bioscience's Accounts Payables stood at $2.1 million in 2021, then decreased by 3.57% to $2.0 million in 2022, then soared by 66.94% to $3.4 million in 2023, then plummeted by 57.0% to $1.5 million in 2024, then increased by 26.72% to $1.8 million in 2025.
- Its last three reported values are $1.8 million in Q3 2025, $1.8 million for Q2 2025, and $1.9 million during Q1 2025.